Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Springerplus
|
June 7, 2013
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
Mariele Dessì, Clelia Madeddu, Alessandra Piras, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2009
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani, Antonio Macciò, Clelia Madeddu, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
Mariele Dessì, Alessandra Piras, Clelia Madeddu, et al.
The Oncologist
|
December 9, 2008
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers
Giovanni Mantovani, Clelia Madeddu, Christian Cadeddu, et al.
Plos One
|
February 4, 2017
Energy expenditure in caving
Giorgia Antoni, Elisabetta Marini, Nicoletta Curreli, et al.
Plos One
|
April 14, 2018
Correction: Energy expenditure in caving
Giorgia Antoni, Elisabetta Marini, Nicoletta Curreli, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
November 4, 2011
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
Clelia Madeddu, Mariele Dessì, Filomena Panzone, et al.
Frontiers in Physiology
|
January 13, 2018
Physical Capacity and Energy Expenditure of Cavers
Virginia Pinna, Sara Magnani, Gianmarco Sainas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Springerplus
|
June 7, 2013
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate
Mariele Dessì, Clelia Madeddu, Alessandra Piras, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2009
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani, Antonio Macciò, Clelia Madeddu, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction
Mariele Dessì, Alessandra Piras, Clelia Madeddu, et al.
The Oncologist
|
December 9, 2008
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers
Giovanni Mantovani, Clelia Madeddu, Christian Cadeddu, et al.
Plos One
|
February 4, 2017
Energy expenditure in caving
Giorgia Antoni, Elisabetta Marini, Nicoletta Curreli, et al.
Plos One
|
April 14, 2018
Correction: Energy expenditure in caving
Giorgia Antoni, Elisabetta Marini, Nicoletta Curreli, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
November 4, 2011
Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
Clelia Madeddu, Mariele Dessì, Filomena Panzone, et al.
Frontiers in Physiology
|
January 13, 2018
Physical Capacity and Energy Expenditure of Cavers
Virginia Pinna, Sara Magnani, Gianmarco Sainas, et al.
Page
of 1